Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome

Pediatric Pulmonology

Volumn 46, Issue 11, 2011, Pages 1079-1084

  Ren, Clement L ^a   Desai, Harsh ^a   Platt, Mary ^a   Dixon, Marissa ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

cystic fibrosis; genetics; infant; newborn screening

Indexed keywords

CHLORINE; ELASTASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

AGE; ALGORITHM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BODY HEIGHT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA DETERMINATION; ENZYME BLOOD LEVEL; FECES ANALYSIS; FEMALE; FOLLOW UP; GENE MUTATION; GENOTYPE; HOSPITALIZATION; HUMAN; IMMUNOREACTIVITY; INFANT; INTERMETHOD COMPARISON; LUNG DISEASE; MALE; NEWBORN SCREENING; OROPHARYNX; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SWEAT TEST;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FECES; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; METABOLIC SYNDROME X; MONITORING, PHYSIOLOGIC; NEONATAL SCREENING; OROPHARYNX; PANCREATIC ELASTASE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SWEAT; TRYPSINOGEN;

EID: 80054969908     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21475     Document Type: Article

References (15)

1. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008; 153: S4-S14. (Pubitemid 351970581)
2. Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, Splaingard M, Mischler EH,. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med 1997; 337: 963-969. (Pubitemid 27425952)
3. Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, Splaingard M, Mischler EH,. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001; 107: 1-13. (Pubitemid 32055408)
4. Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, Douglas JA, Rock MJ, Splaingard ML,. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 2004; 113: 1549-1558. (Pubitemid 38697958)
5. Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, et al. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009; 155: S106-S116.
6. O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R,. Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype. Pediatrics 2006; 118: 1260-1265. (Pubitemid 46090072)
7. Ren CL,. Pulmonary manifestations in deltaF508/R117H. Pediatrics 2007; 119: 647-648.
8. Scotet V, Audrezet MP, Roussey M, Rault G, Dirou-Prigent A, Journel H, Moisan-Petit V, Storni V, Ferec C,. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels ? Pediatrics 2006; 118: e1523-e1529. (Pubitemid 46393657)
9. Carlson D, McKeen E, Mitchell M, Torres B, Parad R, Comeau AM, O'Sullivan BP,. Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care. Pediatr Pulmonol 2009; 44: 497-502.
10. Parad RB, Comeau AM,. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr 2005; 147: S78-S82. (Pubitemid 41400264)
11. Narzi L, Ferraguti G, Stamato A, Narzi F, Valentini SB, Lelli A, Delaroche I, Lucarelli M, Strom R, Quattrucci S,. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up. Clin Genet 2007; 72: 39-46. (Pubitemid 47010146)
12. Sermet-Gaudelus I, Girodon E, Roussel D, Deneuville E, Bui S, Huet F, et al. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis. Thorax 2010; 65: 539-544.
13. Massie J, Clements B,. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience-twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005; 39: 440-446. (Pubitemid 40548286)
14. Thauvin-Robinet C, Munck A, Huet F, Genin E, Bellis G, Gautier E, et al. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening. J Med Genet 2009; 46: 752-758.
15. Sifain MR, Binder A, Voter KZ, Ren CL,. The diagnostic yield of genetic testing in patients with borderline sweat tests. Am J Respir Crit Care Med 2009; 179: A1784.